Article
A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Aug 2018
Pedersen M S, Fahnøe U, Hansen T A, Pedersen A G, Jenssen H, Bukh J, Schønning K
Abstract excerpt
BACKGROUND: The current treatment options for hepatitis C virus (HCV), based on direct acting antivirals (DAA), are dependent on virus genotype and previous treatment experience. Treatment failures have been associated with detection of resistance-associated substitutions (RASs) in the DAA targets of HCV, the NS3, NS5A and NS5 B proteins. OBJECTIVE: To develop a next generation sequencing based method that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
